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Background: Adenomyomectomy has recently been considered the priority option for the treatment of
adenomyosis, however, the surgical efficacy and modes are still debated. We aimed to evaluate the efficacy of
laparoscopic adenomyomectomy using a double-flap method for the treatment of uterine diffuse adenomyosis
when compared with conventional laparoscopic adenomyomectomy.
Methods: Laparoscopic adenomyomectomy using the conventional method (group A, n = 48) and the double-flap
method (group B, n = 46) to treat diffuse uterine adenomyosis, respectively. Visual analog scale (VAS), menstrual
amount, serum CA125 levels, and uterine volume were comparatively analyzed in both groups.
Results: The VAS scores, menstrual amount, serum CA125 levels, and uterine volume at 12 or 24 months after
surgery significantly reduced in group B than in group A (P < 0.05); these parameters were statistically decreased in
both groups after surgery compared with those obtained before surgery (P < 0.001). Moreover, serum CA125 levels
and uterine volume at six months of follow up were significantly lower in group B than in group A (P < 0.01). In
addition, blood loss during surgery was similar in groups A and B (P > 0.05), although the operative time was
significantly longer in group B than that in group A (P < 0.05).
Conclusions: Laparoscopic adenomyomectomy using the double-flap method may be an effective technique to
treat uterine diffuse adenomyosis.
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Adenomyosis is a benign gynecologic disorder charac-
terized by the invasion of endometrial glands and
stroma in the uterine myometrium, resulting in dys-
menorrhea, hypermenorrhea, and infertility [1]. Al-
though adenomyosis may be treated with several
methods, such as hysterectomy, conservative surgery,
drug therapy such as gonadotropin-releasing hormone
agonist therapy (GnRHa), and uterine artery embolization,
complete hysterectomy can thoroughly treat this disease
[2-9]. However, total hysterectomy is not suitable for
women with adenomyosis who want to preserve their
uteri and/or require fertility in the future. As such, these
women prefer uterus-sparing surgery.* Correspondence: zxm20130729@163.com
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unless otherwise stated.Although many uterus-sparing surgical techniques
have been developed to treat adenomyosis, adenomyo-
mectomy is considered as the most feasible and effica-
cious; adenomyomectomy has also been considered as
the first-line approach to treat adenomyosis, particularly
focal adenomyosis [10]. Partial adenomyomectomy in-
cluding wedge resection of the uterine wall, transverse H
incision technique, and asymmetric dissection of uterus
to treat diffuse adenomyosis, can improve clinical symp-
toms; however, these techniques are frequently associ-
ated with adenomyosis recurrence and spontaneous
uterine rupture in pregnancy [2,11-14]. The complete
excision of adenomyosis by employing several tech-
niques, such as overlapping flaps and triple-flap method
to treat diffuse adenomyosis, can achieve good results;
nevertheless, these techniques are difficult to implement,
particularly laparoscopy [15-17]. These findings suggestThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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major concern to improve the convenience of laparo-
scopic conservative surgery to treat diffuse adenomyosis;
with these novel techniques, adenomyotic lesions should
be excised during surgery and uterine wall integrity
should be retained.
Therefore, this study aimed to modify the technique
of Osada et al. to perform laparoscopic adenomyomect-
omy by using a double-flap method for the treatment
of uterine diffuse adenomyosis [16]. This study was also
designed to evaluate the surgical efficacy of laparo-
scopic adenomyomectomy with the modified double-
flap method for women with uterine diffuse adenomyosis,
particularly those who manifested severe clinical symp-
toms and wished to preserve their uteri, but their repro-




The Ethics Committee of the Women’s Hospital, Zhejiang
University School of Medicine approved this study. Writ-
ten informed consent for participation in the study was
obtained from participants.
A total of 129 patients who were referred to our hos-
pital and underwent laparoscopic adenomyomectomy
for uterine diffuse adenomyosis between March 2011
and February 2014 were recruited in this study. The inclu-
sion criteria were listed as follows: ①women had severe
dysmenorrhea with and without menorrhagia (hyperme-
norrhea), but failed to undergo drug therapy, including
GnRHa, Mirena and oral contraceptives;②women wished
to preserve their uteri, but their reproductive capacity was
not a priority request; ③Pure adenomyosis for all the
study subjects was preoperatively verified by ultrasound
and magnetic resonance imaging according to the previ-
ous reported diagnostic criteria [16-26], and affected more
than 70% of the anterior and/or posterior wall of the
uterus with an enlargement of >5 cm in thickness. The ex-
clusion criteria were listed as follows: women presenting
with a contraindication to laparoscopy because of severe
medical illness. The patients who were recruited in this
study were all interviewed by Dr. Huang. During her inter-
view, each patient was in detail told about the advantage
and disadvantage of the conventional method and the
double-flap method (for example, less time and blood loss
but less adenomyotic lesions excised may be in the former,
whereas more time and blood loss but more adenomyotic
lesions excised may be in the latter), and decide whether
to participate in the study, and which method to take.
Consquently, thirty-five among 129 patients who were in-
vited to participate refused treatment. The 94 remaining
patients with diffuse adenomyosis who were included in
this study were assigned to undergo laparoscopicadenomyomectomy by using the conventional method
(group A, n = 48) and the double-flap method (group B,
n = 46) based on patient requirements. After surgery
was completed, all of the patients received GnRHa for
six months. None of the study patients revoked their
consent, failed to undergo follow up, or received sex-
hormone therapy six months before surgery.
Surgical procedure
All surgical procedures were performed under general
anesthesia in the Trendelenburg position with four-port
laparoscopy. One 10 mm port was inserted through the
umbilicus for the zero-degree laparoscope, and two lat-
eral 5 mm ports were inserted above and medial to
each anterior superior iliac spine. A second left sided
5 mm port was inserted between the left lateral port
and the umbilical port. The surgeon (XZ and XH) used
the two left sided ports to perform most of the surgical
procedures.
The technique of resection of adenomyotic lesions
using the double-flap method was previously described
by Osada et al. [16]. In brief, 12 units of pituitrin (di-
luted in 100 ml of normal saline) were injected. An inci-
sion was made in the midline of the serosal surface of
the fundus by using scissors (or monopolar) and contin-
ued along the sagittal direction until the uterine cavity
was reached. The incision was further continued along
the posterior and anterior walls of the uterus to the level
of the internal os of the cervix. Afterward, adenomyoma-
tous tissues were grasped with forceps, identified, and
excised from the surrounding myometrium. This pro-
cedure was performed with care to avoid damaging the
endometrium and the serosal surface of the uterus. If
the myometrium appeared normal, this part was spared
as much as possible. In general, a myometrial thickness
of 1 cm below the serosa or above the endometrium was
left. In addition, this procedure was performed with care
to avoid damaging the interstitial portion of the fallopian
tube, particularly in patients who desired to have future
pregnancies.
After adenomyotic lesions were removed (Figure 1A
and E), the endometrial lining was approximated with
interrupted sutures of 3–0 Vicryl (Figure 1B and F). The
myometrium and serosa of the bisected uterus were su-
tured with 2–0 Vicryl by using the double-flap method
described by Kim et al. [17], but not by using the triple-
flap method proposed by Osada et al. [16]. Namely, the
first flap in one side wall of the uterus (including the ser-
osa and the myometrium) was brought into the second
flap in another side of the uterine wall (including the
endometrium and the myometrium) such that the other
side wall of the uterus (including the endometrium and
the myometrium) was covered (Figure 1C and G). Next,
the second flap in another side of the uterine wall was
Figure 1 Schematic (A, B, C, and D) and surgical view (E, F, G, and H) of laparoscopic adenomyomectomy using the double-flap
method. (A and E) after complete removal of adenomyotic lesions using the resection technique of Osada et al. (B and F) closure and
reconstruction of the uterine cavity using 3–0 absorbable suture. (C and G) the first flap in one side wall of the uterus is brought into the second
flap in another side of the uterine wall such that the other side wall of the uterus is covered. (D and H) the second flap in another side of the
uterine wall is brought to cover the first flap in one side wall of the uterus (before overlapping occurs, the serosal surface of the underlying flaps
is stripped to ensure that only myometrial tissue flaps are overlapped).
Huang et al. BMC Women's Health  (2015) 15:24 Page 3 of 8brought to cover the first flap in one side wall of the
uterus (Figure 1D and H). Before overlapping occurred,
the serosal surface of the underlying flaps was stripped
to ensure that only myometrial tissue flaps overlapped.
During the suture procedure, dead space or hematoma
between the tissues was avoided. The conventional sur-
gical procedure was similar to that of myomectomy and
completely different from the new surgical procedure
(Figure 2). After the surgical procedure, we used INTER-
CEED (an anti adhesion membrane, Johnson company)
to prevent postoperative adhesion. All excised adeno-
myotic tissues were confirmed by histopathology after
surgery.
Follow up
Surgical efficacy was evaluated by rating the levels of
serum CA125, the size of the uterus, and the severity of
dysmenorrhea and hypermenorrhea before and after sur-
gery as well as the presence of pregnancy after surgery
in the two groups. The severity of dysmenorrhea was
documented using a standardized questionnaire with a
visual analog scale (VAS). The pain scale was subdivided
into ten grades. “No pain” was indicated at the left sideof the scale and “the maximum pain you could imagine”
was designated at the right side of the scale. The size of
the uterus was measured by ultrasonography [uterine
volume =A × B ×C × 0.5233 (where A, B, and C are the
uterine length, width, and thickness, respectively)].
Serum CA125 levels were determined by enzyme-linked
immunosorbent assay (ELISA) with a human CA125
ELISA kit (HM10776, Bio-swamp) according to the
manufacturer’s instructions (the normal range was ≤35
kU/L). The menstrual product use of ≥5 pads/day was
defined as menorrhagia in this study; as such, the sever-
ity of menorrhagia was arbitrarily graded as mild (5 to 7
pads/day), moderate (7 to 9 pads/day), and severe (>9
pads/day) [27].
All of the patients were followed up one, three, and six
months after surgery and subsequently every six months
after surgery. Considering that these patients were
treated with GnRHa for six months after surgery, we fo-
cused on two endpoints to determine short- and long-
term surgical treatment efficacies. As such, the results of
the preoperative visit were compared with those of the
12-month follow up and those of the 24-month follow
up to observe the short- and long-term efficacies after
Figure 2 Comparisons of surgical view and schematic of laparoscopic adneomyomectomy using the double-flap method and the
conventional method. (A, C) Conventional method; (B, D) double-flap method.
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the double-flap method and the conventional method to
treat uterine diffuse adenomyosis.
Statistical analysis
We used SPSS version 17.0 (SPSS, IBM, Chicago, IL, USA)
to perform statistical analyses. Results were expressed as
the mean value ± standard derivation (SD), although the
measured values of the variables were not normally distrib-
uted. Mann–Whitney U test was performed to compare
non-parametric data, and chi-square test was conducted to
compare the frequency between groups. Differences were
considered significant at P < 0.05.
Results
No significant differences in age, gravidity, parity, abor-
tion, hemoglobin levels, uterine volume, VAS score,Table 1 Patients’ characteristics (Mean ± SD)
Parameters Group A* (n = 48)
Age at operation(years) 36.6 ± 5.9
Parity 1.1 ± 0.1
Gravidity 3.4 ± 0.2
Abortion 2.3 ± 0.2
Hemoglobin (g/dl) 10.6 ± 2.2
CA125 (kU/L) 108.7 ± 168.9
VAS score 8.1 ± 1.6
Uterine volume (cm3) 198.5 ± 82.6
Menorrhagia (pads) 8.2 ± 1.5
*Group A = Conventional method, Group B = Double-flap method.menorrhagia, and serum CA125 levels were found be-
tween the two groups (P > 0.05, Table 1). Six months
after surgery, five patients (5/48, 10.4%) in group A and
two patients (2/46, 4.3%) in group B still exhibited pain
symptoms with VAS scores of ≤2. The VAS scores at six-
month follow-up period in group A or B significantly de-
creased compared with those before surgery (P <0.0001),
but no statistically significant differences were found be-
tween groups A and B (P > 0.05, Table 2, Figure 3). Uter-
ine size and serum CA125 levels six months after
surgery were significantly higher in group A than in
group B (P < 0.0001), although both parameters in each
group were statistically decreased compared with those
obtained before surgery (P <0.0001, Table 2, Figure 3).
Twelve months after surgery, nine patients (9/31,
29.0%) in group A and three patients (3/27, 11.1%) in
group B manifested pain symptoms, and the VAS scoresGroup B (n = 46) P value
37.1 ± 6.6 0.187
1.1 ± 0.1 0.321
3.5 ± 0.2 0.165
2.4 ± 0.2 0.245
10.8 ± 2.3 0.209
106.5 ± 199.5 0.654
8.2 ± 1.5 0.197
209.1 ± 117.5 0.346
8.1 ± 1.3 0.278
Table 2 Changes in serum CA125 levels, uterine size, pain scores, and menorrhagia after surgery in groups A and B




Group A* (n = 48)
6 months* (n = 48) 20.3 ± 6.9 0.2 ± 0.5 43.0 ± 12.1 ————
12 months (n = 31) 29.4 ± 18.3 0.8 ± 1.1 59.7 ± 24.1 4.2 ± 0.9
24 months (n = 15) 43.8 ± 20.7 2.0 ± 2.1 74.0 ± 30.6 4.6 ± 1.1
Group B (n = 46)
6 months (n = 46) 13.3 ± 3.9 0.1 ± 0.3 37.6 ± 4.6 ————
12 months (n = 27) 19.7 ± 6.2 0.2 ± 0.6 45.8 ± 4.9 3.7 ± 0.6
24 months (n = 13) 25.6 ± 6.7 0.4 ± 0.9 48.1 ± 5.1 3.8 ± 0.6
*Group A = Conventional method, Group B = Double-flap method.
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12 months after surgery compared with those at 6 months
after surgery (P <0.01); the VAS scores increased at
24 months after surgery compared with those at
12 months after surgery (P <0.05). In group B, the VAS
scores were similar between 12 and 6 months after surgery
and between 24 and 12 months after surgery (P > 0.05).
The VAS scores at 12 and 24 months after surgery were
significantly higher in group A than in group B (P <
0.05); these scores in each group were significantly
lower compared with those before surgery (P < 0.0001,
Table 2, Figure 3). Twenty-four months after surgery,
nine patients (9/15, 60.0%) in group A reported pain,
and their highest VAS score was 5.5; by contrast, three
patients (3/13, 23.1%) in group B reported pain, and
their VAS scores were ≤2.5.Figure 3 Changes of serum CA125 levels, uterine size, pain scores, an
Group A = Conventional method, Group B = Double-flap method.Uterine volume significantly increased at 12 months
after surgery compared with those at 6 months after
surgery (P < 0.0001). Furthermore, the uterine volume
of the two groups significantly increased at 24 months
after surgery compared with those at 12 months after
surgery (P < 0.01, Table 2, Figure 3). Uterine sizes at 12
and 24 months after surgery were statistically higher in
group A than in group B (P < 0.0001); uterine size in
each group was significantly decreased after surgery
compared with that before surgery (P < 0.0001, Table 2,
Figure 3). Similar to uterine size, serum CA125 levels at
12 and 24 months after surgery were significantly
higher in group A than in group B (P < 0.05); serum
CA125 levels were also statistically lower than those be-
fore surgery (P = <0.0001, Tables 1 and 2). Differences
in serum CA125 levels between 6 and 12 months andd menorrhagia before and after surgery in groups A and B.
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different in both groups A and group B (P <0.05). In group
B, all of the patients revealed normal serum CA125 levels
at any month after surgery; by contrast, the serum
CA125 levels of six (19.4%) patients in group A at
12 months and seven (46.7%) patients at 24 months
after surgery were >35 kU/L.
The numbers of healthy pads used during menstruation
at 12 and 24 months after surgery were significantly
higher in group A than in group B (P <0.05), but the num-
ber of pads in each group was significantly lower than that
before surgery (P < 0.0001, Table 2, Figure 3). The differ-
ences in menstrual flow between 12 and 24 months after
surgery were not statistically significant in either of the
groups (P > 0.05), although the menstrual flow at
24 months after surgery increased compared with that at
12 months after surgery in both groups (Table 2, Figure 3).
In group B, all of the patients experienced normal men-
struation after surgery. In group A, six (19.4%) patients at
12 months and five (33.3%) patients at 24 months after
surgery suffered from menorrhagia, but the number of
pads used was ≤7.
The amount of blood loss during surgery was similar
in groups A and B (137.5 ± 54.6 ml vs. 145.6 ± 61.6 ml,
P > 0.05). Accordingly, the amount of hemoglobin loss
between before and after surgery was also similar in
groups A and B (0.5 ± 0.26 g/dl vs. 0.6 ± 0.37 g/dl, P >
0.05). The operative time was much more in group B
(152.5 ± 106.9 min) than that in group A (116.7 ±
53.8 min, P < 0.05). Next, the weight of the excised tis-
sues was heavier in group B than that in group A (177 ±
155 g vs. 235.7 ± 201.3 g, P < 0.05). Furthermore, no in-
traoperative or postoperative complications were found
in groups A and B. In addition, ten patients after surgery
in this study (group A = 6, group B = 4) who wished to
have future pregnancies did not want to have a preg-
nancy so far, because they have had children.
Discussion
The present results showed that all of the study patients
exhibited a significant reduction in pain symptoms,
menorrhagia, serum CA125 levels and uterine size after
surgery. Dysmenorrhea and menorrhagia are the charac-
teristic symptoms of adenomyosis, and directly related
to the surgical efficacy of laparoscopic adenomyomect-
omy [9,28,29]. Serum CA125 levels are considered as a
good biomarker to diagnose and monitor the therapeutic
efficacy and recurrence of adenomyosis [30,31]. An en-
larged uterus is also a major symptom of adenomyosis,
and a reduction in uterine size is also directly associated
with therapeutic efficacy [32,33]. It is apparent that lap-
aroscopic adenomyomectomy can treat diffuse uterine
adenomyosis effectively [4,10,34-36]. However, menor-
rhagia, serum CA125 levels and uterine size wereincreased after surgery when postoperative follow up
was prolonged even if we used GnRHa therapy for six
months after operation. It is indicated that the surgical
efficacy of laparoscopic adenomyomectomy for the treat-
ment of diffuse uterine adenomyosis can decrease over
time. Therefore, long-term drug therapy such as Mirena
(or oral contraceptives) is recommeneded after adeno-
myomectomy for the treatment of diffuse uterine adeno-
myosis [17,37].
In fact, the surgical efficacy of adenomyomectomy is
dependent on the type and extent of adenomyosis as
well as the modes of surgery [10,37,38]. Theoretically,
adenomyomectomy can achieve good results for focal
adenomyosis (or adenomyoma), but not for diffuse ade-
nomyosis. Complete resection of adenomyotic lesions
(type I) can have more surgical efficacy compared with
cytoreductive surgery of adenomyosis (type II) [10,37].
In our study, the triple-flap method was modified by
changing the mode of surgery and the suturing method,
but the resection method was retained [16]. Obviously,
the double-flap method is classified as type I, while the
conventional method is classified as type II [10,37]. Our
results showed that the VAS scores, the number of
healthy pads, serum CA125 levels and uterine volume at
12 or 24 months after surgery were all significantly lower
when the double-flap method was used than when the
conventional method was used. Moreover, all of the pa-
tients experienced normal CA125 levels and menstru-
ation, and the VAS scores were similar after surgery
when the double-flap method was used. By contrast,
25% patients still suffered from menorrhagia, about half
of patients showed high serum CA125 levels, and the
VAS scores increased after surgery when the conventional
method was used as follow up time was prolonged. These
results indicate that laparoscopic adenomyomectomy
using the double-flap method was more effective to treat
uterine diffuse adenomyosis than conventional laparo-
scopic adenomyomectomy, which are similar to the previ-
ous reports [10,37].
Recently, Saremi et al. performed open wedge-shaped
adenomyomectomy for 103 patients with adenomyosis,
and 21 (30%) out of 70 patients who attempted preg-
nancy achieved a clinical pregnancy [39]. Kishi et al.
treated 102 patients with adenomyosis who had a desire
for pregnancy by laparoscopic adenomyomectomy using
the conventional method, and the clinical pregnancy
rates in women with age ≤39 years and ≥ 40 year were
41.3% and 3.7%, respectively [40]. In our study, 10 pa-
tients who wished to conceive after surgery did not want
to have a pregnancy so far, because their age were rela-
tively older, and they have had children, which is in
agreement with the study of Kim et al. [17]. Actually,
our study and the study of Kim et al. contain less infer-
tility patients compared with the studies of Kishi et al.
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age >40 years do not show a clear benefit of the surgery
on fertility outcomes after adenomyomectomy for the
treatment of adenomyosis [39]. Furthermore, in patients
with extremely severe diffuse adenomyosis, it is quite diffi-
cult to maintain the intact morphological and functional
reconstruction after complete removal of adenomyotic le-
sions. In such cases, it is hard to tell patients whether they
have a future pregnancy [39]. Therefore, the fear of future
pregnant uterine rupture may also be a factor for our pa-
tients with severe diffuse adenomyosis who do not want
to have a pregnancy at present [41].
Although Kim et al. reconstructed the uterine wall using
the double flap method after laparoscopic-assisted adeno-
myomectomy, yet, their resection method quite differs
from our resection method [17]. As matter of fact, we ini-
tially try to perform open adenomyomectomy by using the
technique of Osada et al. [16]. When we find it is ex-
tremely difficult to reconstruct the uterine wall using the
triple-flap method in despite of a new absorbable barbed
suture (v-loc) [16,37], then we try to suture using the
double flap method. After we have mastered the technique
of the double flap method, we perform a laparoscopic sur-
gery. During the surgical procedure, a diluted solution of
pituitrin was first injected until the uterus became white
colour, and then the remained pituitrin solution was con-
tinually used when it was needed. In the meantime, a
drainage tube used as a tourniquet for transient occlusion
of uterine arteries was placed into the abdominal cavity in
case of massive bleeding during the procedure [42]. More-
over, the uterine cavity was opened so that the entire ex-
tent of the adenomyosis, the crucial landmarks of the
endometrium and the serosal surface are clearly visible
[16]. We found no patients required conversion to open
surgery, and the blood loss was similar in the two
methods, although the double-flap method had more op-
erative time compared with the conventional method.
Interestingly, the amount of the blood loss in our study
(145.6 ml) is less compared with the study of Kim et al.
(383.3 ml), while the operative time is a little longer in our
study (152.5 min) in comparison with the study of Kim
et al. (130.6 min) [17]. Moreover, no intraoperative or
postoperative complications were observed in all of the
study patients. In addition, complete removal of the ade-
nomyotic lesions may create better uterine conditions for
pregnancy [16]. Therefore, the double-flap method could
be safe and effective to treat uterine diffuse adenomyosis,
although future follow-up observation is needed for post-
operative pregnancy and childbirth in order to verify the
robustness of the uterine reconstruction.
Conclusions
Our results showed that women with diffuse adenomyo-
sis exhibited a significant reduction in serum CA125levels, uterine size, hypermenorrhea, and dysmenorrhea
after laparoscopic adenomyomectomy was performed
using the double-flap method. These results suggest
that adenomyomectomy with the double-flap method
may be a good therapeutic option for women with diffuse
uterine adenomyosis and wish to avoid hysterectomy.
Nevertheless, further studies should be conducted to ver-
ify these results.
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